President
Axendia Inc.
Daniel R. Matlis is Founder and President of Axendia, a research analyst firm providing trusted advice to Life-Science Executives on Business, Technology and Regulatory issues. Dan has three decades of industry experience spanning the Life-Science value chain.
He is an active contributor to FDA’s Case for Quality Initiative (since 2014), is a member of FDA’s Advisory Council on Modeling, Simulation and in-Silico Clinical Trial, has co-chaired the Product Quality Outcomes Analytics initiative with Agency officials and has provided input to the Agency on the Computer Software Assurance guidance.
Dan began his career at Johnson & Johnson, where he provided leadership in the areas of technology, regulatory compliance, and business. Before founding Axendia, Dan was a Partner, VP and General Manager at a leading Life-Science consultancy firm.
Dan presented Axendia’s research findings to industry executives and the FDA officials. He is a frequent lecturer at Industry events and has published numerous research reports and articles on key issues facing the Life-Sciences and Healthcare industries.
Dan holds a BS in Electrical Engineering from Polytechnic University (now NYU School of Engineering) in NY and a MS in Management from the New Jersey Institute of Technology.
Disclosure information not submitted.
Monday, September 12, 2022
11:15 AM – 11:40 AM MST